Antibiotic Treatment for Infections of Short Term In-dwelling Vascular Catheters Due to Gram Positive Bacteria

• Status: Completed
• Trial end date: 2005-07-01
• Target enrollment: 0
• Participant gender: All

Summary

This study will treat patients who have a short term central catheter that is thought to be infected with a specific bacteria (gram positive bacteria)

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Pfizer
• Treatments: Dicloxacillin; Linezolid; Oxacillin; Vancomycin

Criteria

Inclusion Criteria:

• Patients with a central indwelling catheter with signs and symptoms of infection

Exclusion Criteria:

• Patients with tunneled catheter which cannot be removed.

• Patients with evidence of endovascular infection including endocarditis.

• Patients with infection of permanent intravascular devices.

• Patients who have received more than 1 day of another antibiotic before enrollment.

• Patients with HIV and low CD4 count.